Shang-Jui Wang

6PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersRadiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 15, 2026
Racial Disparities in Survival Outcomes for Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A SEER-Based Retrospective Analysis (2010-2020).

|Jan 19, 2026
Change in Clinical Management of Localized Prostate Cancer Patients at a Tertiary Medical Center as a Result of SARS-CoV-2 (COVID-19).

Alexander Yaney, Jonathan E Schoenhals, Yevgeniya Gokun

|Jun 25, 2025
Evaluating the Impact of Common Non-Oncologic Medication Use During Radiotherapy in Patients with High-Risk Prostate Cancer.

Haley K Perlow, Karishma Khullar, Ritesh Kumar

|Jun 26, 2024
Patient-Derived Conditionally Reprogrammed Cells in Prostate Cancer Research.

Abdalla Elbialy, Deepthi Kappala, Dhruv Desai

|Dec 22, 2023
Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma.

Rohit K Raj, Rituraj Upadhyay, Shang-Jui Wang

|Oct 06, 2020
Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer.

Shang-Jui Wang, Karishma Khullar, Sinae Kim

Pageof 1

Frequent Collaborators

2 joint publications

Xuefeng Liu

1 joint publications

Roman Groisberg

1 joint publications

Ann W Silk

1 joint publications

Mina S Makary